Asthma - Versorgungsleitlinien.de
Asthma - Versorgungsleitlinien.de
Asthma - Versorgungsleitlinien.de
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
NVL <strong>Asthma</strong>, 2. Auflage<br />
Langfassung<br />
Juli 2011, Version 1.3<br />
327. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, Bateman ED.<br />
Bu<strong>de</strong>soni<strong>de</strong>/formoterol combination therapy as both maintenance and reliever medication in<br />
asthma. Am J Respir Crit Care Med 2005;171(2):129-36.<br />
328. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus<br />
doubling the dose of beclomethasone in children with asthma. The Dutch <strong>Asthma</strong> Study<br />
Group. Am J Respir Crit Care Med 1998;158(1):213-9.<br />
329. Gappa M, Zachgo W, von BA, Kamin W, Stern-Strater C, Steinkamp G. Add-on salmeterol<br />
compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial<br />
(VIAPAED). Pediatr Pulmonol 2009;44(11):1132-42.<br />
330. Bisgaard H, Le RP, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Bu<strong>de</strong>soni<strong>de</strong>/formoterol<br />
maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest<br />
2006;130(6):1733-43.<br />
331. Russell G, Williams DA, Weller P, Price JF. Salmeterol xinafoate in children on high dose<br />
inhaled steroids. Ann Allergy <strong>Asthma</strong> Immunol 1995;75(5):423-8.<br />
332. <strong>de</strong> Blic J, Ogorodova L, Klink R, Sidorenko I, Valiulis A, Hofman J, Bennedbaek O, An<strong>de</strong>rton S,<br />
Attali V, Desfougeres JL, Poterre M. Salmeterol/fluticasone propionate vs. double dose<br />
fluticasone propionate on lung function and asthma control in children. Pediatr Allergy<br />
Immunol 2009;20(8):763-71.<br />
333. van A<strong>de</strong>lsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF. Safety, tolerability, and<br />
exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma. Curr Med<br />
Res Opin 2005;21(6):971-9.<br />
334. Knorr B, Maganti L, Ramakrishnan R, Tozzi CA, Migoya E, Kearns G. Pharmacokinetics and<br />
safety of montelukast in children aged 3 to 6 months. J Clin Pharmacol 2006;46(6):620-7.<br />
335. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P.<br />
Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent<br />
asthma. Am J Respir Crit Care Med 2005;171(4):315-22.<br />
336. Robertson CF, Price D, Henry R, Mellis C, Glasgow N, Fitzgerald D, Lee AJ, Turner J, Sant M.<br />
Short-course montelukast for intermittent asthma in children: a randomized controlled trial.<br />
Am J Respir Crit Care Med 2007;175(4):323-9.<br />
337. Straub DA, Minocchieri S, Moeller A, Hamacher J, Wildhaber JH. The effect of montelukast on<br />
exhaled nitric oxi<strong>de</strong> and lung function in asthmatic children 2 to 5 years old. Chest<br />
2005;127(2):509-14.<br />
338. Hakim F, Vilozni D, Adler A, Livnat G, Tal A, Bentur L. The effect of montelukast on bronchial<br />
hyperreactivity in preschool children. Chest 2007;131(1):180-6.<br />
339. Lex C, Zacharasiewicz A, Payne DN, Wilson NM, Nicholson AG, Kharitonov SA, Barnes PJ,<br />
Bush A. Exhaled breath con<strong>de</strong>nsate cysteinyl leukotrienes and airway remo<strong>de</strong>ling in<br />
childhood asthma: a pilot study. Respir Res 2006;7:63.<br />
340. Amirav I. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to mo<strong>de</strong>rate<br />
asthma. Isr Med Assoc J 2008;10(4):287-91.<br />
Gilt nur für<br />
Erwachsene<br />
Gilt nur für<br />
Kin<strong>de</strong>r/Jugendliche<br />
Allgemeine<br />
Empfehlungen<br />
© 2009 224
Change language